Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore

Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore

10.3802/jgo.2021.32.e27

محفوظ في:

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Tan, David SP, Chan, Jack Junjie, Hettle, Robert, Ghosh, Wrik, Viswambaram, Amrita, Yu, Cindy Chen
مؤلفون آخرون:	MEDICINE
التنسيق:	مقال
منشور في:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy 2021
الوصول للمادة أونلاين:	https://scholarbank.nus.edu.sg/handle/10635/185760
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

Cost-effectiveness of olaparib vs routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore
بواسطة: Tan, DS, وآخرون
منشور في: (2021)

A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)
بواسطة: Lee, Yong Jae, وآخرون
منشور في: (2021)

Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4
بواسطة: Kim, YN, وآخرون
منشور في: (2023)

Case report: olaparib use in metastatic lung adenocarcinoma with BRCA2 pathogenic variant
بواسطة: Soon, Jonathan Jian Hao, وآخرون
منشور في: (2023)

cis-Platinum-based chemotherapy in management of malignant ovarian germ cell tumors
بواسطة: V. Linasmita, وآخرون
منشور في: (2018)

Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status
بواسطة: Marijon, Hélène, وآخرون
منشور في: (2022)

Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families
بواسطة: Kang, P., وآخرون
منشور في: (2014)

A role for Brca1 in chromosome end maintenance
بواسطة: McPherson, J.P., وآخرون
منشور في: (2011)

UTILIZATION OF GENOM DNA FOR NON-INVASIVE DETECTION OF BRCA1 GENE MUTATIONS IN OVARIAN CANCER PATIENTS
بواسطة: Fadiyah, Farizul

Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer.
بواسطة: Pimpicha Patmasiriwat, وآخرون
منشور في: (2018)

Potential predictors for chemotherapeutic response and prognosis in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy
بواسطة: Dhammapoj Jeerakornpassawat, وآخرون
منشور في: (2020)

Adding bevacizumab to single agent chemotherapy for the treatment of platinum-resistant recurrent ovarian cancer: A cost effectiveness analysis of the AURELIA trial
بواسطة: Wysham, Weiya Z, وآخرون
منشور في: (2023)

Epithelial Ovarian Cancer Treated by Platinum or Platinum Analogue with Cyclophosphamide : Experience in Ramathibodi Hospital
بواسطة: Vasant Linasmita, وآخرون
منشور في: (2018)

HIGHWAY ROUTINE MAINTENANCE PROGRAMMING AT NETWORK LEVEL.
بواسطة: Fwa, Tien Fang, وآخرون
منشور في: (2014)

Prevalence of tissue BRCA gene mutation in ovarian, fallopian tube, and primary peritoneal cancers: A multi-institutional study
بواسطة: Arb Aroon Lertkhachonsuk, وآخرون
منشور في: (2020)

Functional analysis of familial Asp67Glu and Thr1051Ser BRCA1 mutations in breast/ovarian carcinogenesis
بواسطة: Malinee Pongsavee, وآخرون
منشور في: (2018)

Prevalence of tissue BRCA gene mutation in ovarian, fallopian tube, and primary peritoneal cancers: A multi-institutional study
بواسطة: Arb Aroon Lertkhachonsuk, وآخرون
منشور في: (2020)

Functional Analysis of Familial Asp67Glu and Thr1051Ser BRCA1 Mutations in Breast/Ovarian Carcinogenesis
بواسطة: Malinee Pongsavee, وآخرون
منشور في: (2012)

Genetic changes resulting in breast and ovarian cancers in BRCA 1/2 negative families in Thailand
بواسطة: Malinee Pongsavee
منشور في: (2023)

Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer
بواسطة: Lim, Y.K., وآخرون
منشور في: (2012)

Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer
بواسطة: Lim, Y.K., وآخرون
منشور في: (2011)

The use of lenograstim (Granocyte®) in chemotherapy for ovarian cancer
بواسطة: Anuvat Roongpisuthipong, وآخرون
منشور في: (2018)

Cancer-causing BRCA2 missense mutations disrupt an intracellular protein assembly mechanism to disable genome maintenance
بواسطة: Lee, Miyoung, وآخرون
منشور في: (2022)

Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy
بواسطة: Molassiotis, A., وآخرون
منشور في: (2021)

BRCA1 disease-associated haplotypes in Singapore Malay women with early-onset breast/ovarian cancer
بواسطة: Ali, A.B., وآخرون
منشور في: (2012)

IDENTIFICATION AND CHARACTERISATION OF BRCA GENOMIC REARRANGEMENT IN SINGAPORE PATIENTS WITH EARLY ONSET OR FAMILIAL BREAST AND/OR OVARIAN CANCER
بواسطة: LIM YEW KOON
منشور في: (2019)

BRCA1 c.2845insA is a founder mutation in Singaporean Malay women with early onset breast/ovarian cancer.
بواسطة: Sng, J.H., وآخرون
منشور في: (2014)

Platinum(IV) carboxylate prodrug complexes as versatile platforms for targeted chemotherapy
بواسطة: Ong, Jun Xiang, وآخرون
منشور في: (2016)

BRCA1 mutations in the family history clinic
بواسطة: IAU TSAU CHOONG, PHILIP
منشور في: (2010)

Compensatory functions and interdependency of the DNABinding domain of BRCA2 with the BRCA1-PALB2-BRCA2 complex
بواسطة: Muthana Al Abo, وآخرون
منشور في: (2018)

BRCA1 and BRCA2 mutations in an Asian clinic-based population detected using a comprehensive strategy
بواسطة: Ang, P., وآخرون
منشور في: (2015)

Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries
بواسطة: Cherry Lim, وآخرون
منشور في: (2022)

BRCA1 c.2845insA is a recurring mutation with a founder effect in Singapore Malay women with early onset breast/ovarian cancer.
بواسطة: Sng, J.H., وآخرون
منشور في: (2014)

The correlation of nutritional status with hematology toxicity of adjuvant chemotherapy in ovarian cancer
بواسطة: Kadek Dharma Widhiarta, -, وآخرون
منشور في: (2021)

The BRCA1 3'-UTR: 5711+421T/T_5711+1286T/T genotype is a possible breast and ovarian cancer risk factor.
بواسطة: Malinee Pongsavee, وآخرون
منشور في: (2018)

Detection of recurrence in a surveillance program for epithelial ovarian cancer
بواسطة: Prapaporn Suprasert, وآخرون
منشور في: (2018)

Detection of recurrence in a surveillance program for epithelial ovarian cancer
بواسطة: Suprasert P., وآخرون
منشور في: (2014)

Detection of recurrence in a surveillance program for epithelial ovarian cancer
بواسطة: Prapaporn Suprasert, وآخرون
منشور في: (2018)

Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer
بواسطة: Hoppe, Michal M, وآخرون
منشور في: (2021)

BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity
بواسطة: Tacconi, E.M.C, وآخرون
منشور في: (2020)